| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |